Delta Manuf Peer Comparison

NSE: DELTAMAGNT | BSE: 504286

₹53.55

₹-0.90 (-1.65%)

As on 03-Nov-2026IST

Market cap

₹60 Cr

Revenue (TTM)

₹67 Cr

P/E Ratio

P/B Ratio

24.5

Div. Yield

0 %

Edit

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Market cap (₹ Cr)	60	8,423	297	218	35
Revenue (₹ Cr)	67	22,882	82	434	181
Net Profit (₹ Cr)	-7.30	422.61	10.62	17.44	2.66
Net Margin (%)	0.51	1.84	12.59	3.90	1.42
RoE (%)	-47.21	7.66	9.30	6.80	2.82
Price to Earnings	--	19.93	27.97	12.50	16.63
Price-To-Book	24.50	1.38	2.39	0.84	0.48

Income Statement (₹ Cr)

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Operating Revenue	61.87	23,505.54	80.43	430.87	130.23
Total Income	63.37	23,662.81	83.18	442.48	133.35
Total Expenditure	57.54	21,745.77	64.21	407.51	123.85
EBITDA	4.33	1,759.77	16.22	23.37	6.38
Depreciation	2.76	197.38	4.38	10.92	3.37
EBIT	1.57	1,562.39	11.84	12.45	3.01
Interest	0.79	871.74	0.56	12.97	11.88
Other Income	1.50	157.27	2.75	11.60	3.13
Exceptional Items	0.09	-58.78	-0.60	11.95	--
Profit before Tax	-0.99	789.14	13.44	11.08	-5.74
Provision for Tax	0.08	183.55	3.63	1.61	0.36
Profit after Tax	-1.06	605.59	9.81	9.47	-6.11

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Shareholder's Funds	2.31	6,159.69	122.45	257.94	72.51
Minority Interest	--	--	--	--	27.41
Non-Current Liabilities	8.14	515.16	2.31	68.01	65.54
Current Liabilities	55.00	18,007.82	9.40	236.55	102.48
Total Liabilities	68.45	25,133.45	134.69	567.57	267.94

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Non-Current Assets	39.29	2,473.59	75.09	313.41	90.00
Current Assets	26.27	22,209.08	59.07	249.09	177.94
Total Assets	68.45	25,133.45	134.69	567.57	267.94
Total Debt*	39.12	5,103.23	2.43	148.60	137.07
Net Current Assets	-28.73	4,201.26	49.67	12.55	75.45
Contingent Liabilities	4.61	188.22	2.67	16.95	--

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Cash From Operating Activities	0.66	-414.12	12.08	14.25	-6.74
Cash Flow from Investing Activities	-9.76	-241.80	-10.09	-8.24	24.74
Cash from Financing Activities	9.44	510.97	-5.36	-3.75	-18.30
Net Cash Inflow / Outflow	0.34	-144.95	-3.37	2.26	-0.29

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
ROCE (%)	-0.48	16.35	11.43	6.08	3.19
ROE (%)	-12.57	10.53	8.31	3.76	-9.25
ROA (%)	-1.56	2.61	7.52	1.74	-2.44
EBIT Margin (%)	9.42	8.16	23.59	8.12	7.30
Net Margin (%)	-1.68	2.56	11.79	2.14	-4.58
Cash Profit Margin (%)	2.75	3.42	17.64	4.72	-2.10

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Revenue Growth (%)	10.80	7.59	16.72	-2.78	-21.66
EBIT Growth (%)	33.58	9.54	18.11	-3.51	-61.80
Net Profit Growth (%)	-250.62	6.11	27.10	-64.58	-158.60
EPS Growth (%)	-2.64	6.11	27.10	-64.58	-124.45
Book Value Growth (%)	-84.21	15.19	7.79	5.20	9.39

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Price / Earnings	0.00	22.49	13.36	18.22	0.00
Price / Book Value	21.65	2.21	1.07	0.67	0.94
Dividend Yield (%)	0.00	1.08	0.91	0.00	0.00
EV/EBITDA	15.18	9.50	6.00	9.09	21.23
Market Cap (₹ Cr)	49.91	13,619.11	131.05	172.48	64.93

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Debt to Equity	16.97	0.83	0.02	0.58	1.99
Short term debt to equity ratio	14.97	0.68	0.03	0.41	0.97
Current Ratio	0.48	1.23	6.28	1.05	1.74
Quick Ratio	0.33	1.15	4.84	0.60	1.33
Interest Coverage	-0.25	1.91	25.20	1.85	0.52

	Delta Manuf	KEC International	Tamboli Capital	Gillanders Arbuthnot	Indrayani Biotech
Debtors to sales (%)	19.80	27.54	27.55	14.66	45.07
Asset Turnover	0.91	1.01	0.62	0.80	0.52
Receivable days	79.88	89.48	87.30	52.78	137.64
Inventory Days	57.53	20.76	61.62	83.71	117.29
Payable days	149.50	238.84	135.35	179.84	134.44
Cash Conversion Cycle	-12.09	-128.60	13.57	-43.36	120.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.